Update on reducing the development of diabetic kidney disease and cardiovascular death in diabetes.
作者信息
Bakris George L
机构信息
Department of Medicine, American Society of Hypertension Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois, USA.
出版信息
Kidney Int Suppl (2011). 2018 Jan;8(1):1. doi: 10.1016/j.kisu.2017.10.002. Epub 2017 Dec 29.
Abstract
摘要
相似文献
1
Update on reducing the development of diabetic kidney disease and cardiovascular death in diabetes.降低糖尿病肾病发生及糖尿病心血管死亡的研究进展
Kidney Int Suppl (2011). 2018 Jan;8(1):1. doi: 10.1016/j.kisu.2017.10.002. Epub 2017 Dec 29.
2
Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.蛋白尿 2 型糖尿病和肾病患者发生终末期肾病与心血管死亡率的相对发生率：来自 DIAMETRIC（糖尿病肾脏并发症防治研究联盟）数据库的结果。
Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3.
3
Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.2 型糖尿病肾病患者的血压变异性与肾脏和心血管结局：来自 RENAAL 研究和厄贝沙坦糖尿病肾病试验的事后分析。
Am J Kidney Dis. 2014 Nov;64(5):714-22. doi: 10.1053/j.ajkd.2014.06.008. Epub 2014 Jul 24.
4
[Update on Diabetic Kidney Disease 2018].[2018年糖尿病肾病最新进展]
Ther Umsch. 2018;75(6):355-357. doi: 10.1024/0040-5930/a001008.
5
Diabetes, hypertension, and cardiovascular disease: an update.糖尿病、高血压与心血管疾病：最新进展
Hypertension. 2001 Apr;37(4):1053-9. doi: 10.1161/01.hyp.37.4.1053.
6
Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials.糖尿病肾病的心血管结局：近期临床试验的见解
Kidney Int Suppl (2011). 2018 Jan;8(1):8-17. doi: 10.1016/j.kisu.2017.10.004. Epub 2017 Dec 29.
7
Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.血浆 copeptin、肾脏疾病与 2 型糖尿病两种队列的心血管发病率和死亡率风险。
Cardiovasc Diabetol. 2018 Aug 2;17(1):110. doi: 10.1186/s12933-018-0753-5.
8
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).血清碳酸氢盐与糖尿病肾病患者的肾脏疾病进展和心血管结局：RENAAL（氯沙坦干预降低非胰岛素依赖型糖尿病肾病进展）研究和 IDNT（厄贝沙坦糖尿病肾病试验）的事后分析
Am J Kidney Dis. 2015 Sep;66(3):450-8. doi: 10.1053/j.ajkd.2015.03.032. Epub 2015 May 16.
9
Cardiovascular complications of type 1 diabetes: update on the renal link.1型糖尿病的心血管并发症：肾脏关联的最新进展
Acta Diabetol. 2017 Apr;54(4):325-334. doi: 10.1007/s00592-016-0949-7. Epub 2016 Dec 19.
10
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.二甲双胍在 2 型糖尿病合并慢性肾脏病患者中的应用与心血管事件。
Diabetes Obes Metab. 2019 May;21(5):1199-1208. doi: 10.1111/dom.13642. Epub 2019 Mar 4.
引用本文的文献
1
Association between red blood cell distribution width to serum calcium ratio and all-cause mortality in critically ill patients with diabetic nephropathy: a retrospective analysis of the MIMIC-IV database.糖尿病肾病重症患者红细胞分布宽度与血清钙比值和全因死亡率之间的关联：MIMIC-IV数据库的回顾性分析
BMC Nephrol. 2025 Aug 20;26(1):475. doi: 10.1186/s12882-025-04402-x.
2
Associations of the TyG index with albuminuria and chronic kidney disease in patients with type 2 diabetes.TyG 指数与 2 型糖尿病患者蛋白尿和慢性肾脏病的相关性。
PLoS One. 2024 Oct 28;19(10):e0312374. doi: 10.1371/journal.pone.0312374. eCollection 2024.
3
Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease.三酰甘油-葡萄糖指数与 2 型糖尿病合并慢性肾脏病患者发生终末期肾病风险的关系。
Front Endocrinol (Lausanne). 2023 Apr 20;14:1150980. doi: 10.3389/fendo.2023.1150980. eCollection 2023.
4
Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK.在患有 2 型糖尿病和糖尿病肾病的人群中，死亡率和终末期肾病的发生率及风险因素：一项基于人群的英国队列研究。
BMJ Open Diabetes Res Care. 2021 Oct;9(1). doi: 10.1136/bmjdrc-2021-002146.
本文引用的文献
1
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.国际糖尿病联盟糖尿病地图：2015年和2040年全球糖尿病患病率估计
Diabetes Res Clin Pract. 2017 Jun;128:40-50. doi: 10.1016/j.diabres.2017.03.024. Epub 2017 Mar 31.
2
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.恩格列净与2型糖尿病肾病进展
N Engl J Med. 2016 Nov 3;375(18):1801-2. doi: 10.1056/NEJMc1611290.
3
Changes in diabetes-related complications in the United States, 1990-2010.美国 1990-2010 年糖尿病相关并发症的变化。
N Engl J Med. 2014 Apr 17;370(16):1514-23. doi: 10.1056/NEJMoa1310799.
Zotero 插件